Navigation Links
Setting a course for the future of tissue engineering

New Rochelle, NY, December 11, 2007 The editors of Tissue Engineering asked 24 leaders in the field what critical steps are needed for tissue engineering to achieve broad critical success by the year 2021 and published their findings in the December 2007 issue (Volume 13, Number 12). Tissue Engineering is a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online.

A survey of the journals editorial boardcomprising leaders in the field of tissue engineering from around the globeyielded a clear picture of the key scientific areas in which researchers need to focus their efforts. Authors Peter Johnson, MD, Co-Editor-in-Chief of Tissue Engineering and President and CEO of Scintellix, LLC, as well as Co-Editor-in-Chief Antonios Mikos, PhD, from Rice University in Houston, TX, John Fisher, PhD, from the University of Maryland, College Park, and John Jansen, DDS, PhD, from Radboud University Nijmegen Medical Center, The Netherlands, present a consensus opinion of these critical paths for development and discuss their implications for the field in a report entitled, "Strategic Directions in Tissue Engineering.

These findings can help scientists in academia and industry, teachers, and funding agencies plan for the future, design research projects and training programs, and set a course to enable the field of tissue engineering to reach its goals and potential for success in clinical medicine.

Our worldwide editorial board was very helpful in sharing critical opinions regarding the future of tissue engineering. We hope that this offering will prove to be useful to all participants in the field says Dr. Johnson.

Leading the list of strategic initiatives is angiogenic control, which defines the ability to provide engineered tissues with an adequate blood supply to nourish their development and survival. Next on the list is stem cell science, which encompasses an understanding of stem cell behavior and how to control their growth, development, and function. Also included among the leading strategic goals identified in the survey is molecular/systems biology, which describes the importance of integrating knowledge about tissues at the cellular and molecular level with a broader view of how they affect and are affected by the organism as a whole.


Contact: Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News

Related biology news :

1. Environmental setting of human migrations in the circum-Pacific Region
2. Leading cause of death in preemies might be controlled by resetting a molecular switch
3. Great Plains historical stability vulnerable to future changes
4. Gene may hold key to future cancer hope
5. DOE publishes update of plan: Facilities for the Future of Science: A 20-Year Outlook
6. NASA technology helps predict and prevent future pandemic outbreaks
7. Sunbathing tree frogs future under a cloud
8. Methane from microbes: a fuel for the future
9. A step toward tissue-engineered heart structures for children
10. Researchers create system to build transplant tissue
11. Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues
Post Your Comments:
(Date:10/26/2015)... 2015  Delta ID Inc., a company focused on ... PC devices, announced its ActiveIRIS® technology powers the iris ... launched by NTT DOCOMO, INC in Japan ... smartphone to include iris recognition technology, after a very ... in May 2015, world,s first smartphone to have this ...
(Date:10/23/2015)... GOLETA, California , October 23, 2015 ... Instruments (SMI) announce a mobile plug and play integration ... interactive real-world tasks SensoMotoric Instruments (SMI) ... established wearable solutions for eye tracking and physiological data ... with SMI Eye Tracking Glasses 2w and ...
(Date:10/22/2015)... -- Synaptics (NASDAQ: SYNA ), a leading developer of human interface ... 30, 2015. --> --> ... percent over the comparable quarter last year to $470.0 million. Net ... or $0.62 per diluted share. --> ... fiscal 2016 grew 39 percent over the prior year period to ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ), a ... closed the sale of its global contrast media and ... in a transaction valued at approximately $270 million. The ... total of approximately 1,000 employees spread across the globe, ... area. This entire workforce and the manufacturing ...
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... HART ), a biotechnology company developing bioengineered organ implants ... McGorry will present at the LD Micro "Main ... 2:30 p.m. PT. The presentation will be webcast live ... Management will also be available at the conference for ...
Breaking Biology Technology: